|
|
 |
|
Viewing report
|
|
|
|
Ovarian Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2006, Pages: 248
This report analyzes the worldwide markets for Ovarian Cancer Therapeutics in Millions of US$. The major product segments analyzed are Localized Ovarian Cancer Therapeutics, Metastatic Ovarian Cancer Therapeutics, and Refractory Ovarian Cancer Therapeutics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 42 companies including many key and niche players worldwide such as Alza Corporation, Amgen, Inc., Bristol-Myers Squibb, Cell Therapeutics, Inc., Genentech Inc., GlaxoSmithkline, Immunogen, Inc., Ivax, OSI Pharmaceuticals, and Raven Biotechnologies, Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and New Developments
25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001
Cancer Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Cancer Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Current Therapies for Ovarian Cancer
Stakeholder Opinions: Ovarian Cancer - Beyond Carboplatin and Paclitaxel
New Concepts in Cancer Therapeutics
|
|
|
|
